1.Clostridium difficile Infection: A Worldwide Disease.
Kristin E BURKE ; J Thomas LAMONT
Gut and Liver 2014;8(1):1-6
Clostridium difficile, an anaerobic toxigenic bacterium, causes a severe infectious colitis that leads to significant morbidity and mortality worldwide. Both enhanced bacterial toxins and diminished host immune response contribute to symptomatic disease. C. difficile has been a well-established pathogen in North America and Europe for decades, but is just emerging in Asia. This article reviews the epidemiology, microbiology, pathophysiology, and clinical management of C. difficile. Prompt recognition of C. difficile is necessary to implement appropriate infection control practices.
Asia/epidemiology
;
Clostridium Infections/*diagnosis/epidemiology/microbiology/*therapy
;
Clostridium difficile/genetics/*pathogenicity
;
Europe/epidemiology
;
Global Health
;
Humans
;
North America/epidemiology
2.Pigbel in the 21st century: still here, and still in need of an effective surveillance system.
Duke T ; Poka H ; Myers S ; Radcliffe J ; Pavlin BI.
Papua New Guinea medical journal 2013;56(3-4):136-140
Pigbel remains a likely significant cause of morbidity and mortality in the highlands of Papua New Guinea (PNG), two decades after the administration of pigbel vaccination ceased. There is a need for an effective surveillance program for pigbel to better understand the disease burden and to target communities for preventive strategies. This paper reviews the epidemiology, pathogenesis, recent history and current data on the burden of pigbel in PNG. We propose a surveillance program based on clinical recognition of likely cases and laboratory confirmation using an ELISA assay for Clostridium perfringens type C beta-toxin. Research aimed at validating this approach in the clinical setting is outlined.
Clostridium Infections/epidemiology/*microbiology/*prevention & control
;
Clostridium perfringens/pathogenicity
;
Enteritis/epidemiology/*microbiology/*prevention & control
;
Health Services Needs and Demand
;
Humans
;
Incidence
;
Papua New Guinea/epidemiology
;
Population Surveillance
4.Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection.
Saeam SHIN ; Minkyung KIM ; Myungsook KIM ; Heejung LIM ; Heejung KIM ; Kyungwon LEE ; Yunsop CHONG
Annals of Laboratory Medicine 2012;32(5):355-358
Infection with Clostridium difficile is a growing concern because of the increasing prevalence and spread of nosocomial infections. Emergence of the hypervirulent 027/NAP1/BI strain is also notable. Existing diagnostic methods have low sensitivity or are time-consuming. Therefore, establishing a rapid and accurate microbiological diagnostic assay is needed. We evaluated the Xpert C. difficile assay (Xpert CD assay; Cepheid, USA) to detect toxigenic C. difficile. This assay is a real-time multiplex PCR assay that can be used to detect toxigenic C. difficile strains and differentiate the C. difficile presumptive 027/NAP1/BI strain. A total of 253 loose stool specimens were collected and toxigenic cultures, VIDAS C. difficile A & B assays (VIDAS CDAB assay; bioMerieux, France), and the Xpert CD assay were performed. In comparison to toxigenic cultures, the sensitivity, specificity, and positive and negative predictive values were 100%, 94.6%, 83.1%, and 100%, respectively, for the Xpert CD assay and 40.8%, 98.0%, 100%, and 88.9%, respectively, for VIDAS CDAB assay. Because of the low prevalence of the PCR ribotype 027 in Korea, the evaluation of the usefulness of the Xpert CD assay for screening for the 027 strain was limited. The Xpert CD assay provides great sensitivity in diagnosing toxigenic C. difficile infection. In addition, this method has excellent usability because it is simple and fast.
Clostridium Infections/*diagnosis/epidemiology/microbiology
;
Clostridium difficile/genetics/*isolation & purification/metabolism
;
Face/microbiology
;
Humans
;
Multiplex Polymerase Chain Reaction
;
Prevalence
;
Reagent Kits, Diagnostic/*standards
;
Sensitivity and Specificity
5.Increase of Clostridium difficile in Community; Another Worrisome Burden for Public Health.
Young Ah KIM ; John Hoon RIM ; Min Hyuk CHOI ; Heejung KIM ; Kyungwon LEE
Annals of Clinical Microbiology 2016;19(1):7-12
BACKGROUND: Increasing rates of Clostridium difficile infection (CDI) have been reported mainly in Europe and North America; however, only limited reports have originated in Korea. The current epidemiology of CDI in the community could help to understand the outpatient healthcare environment and to extend infection control measures to outpatient settings. METHODS: C. difficile isolates in NHIS Ilsan Hospital from 2012 to 2014 were included in this study. Clinical characteristics, acquisition types, and previous antimicrobial therapy were obtained via Electronic Medical Records. C. difficile culture was performed only in unformed stool. Toxin was positive by enzyme-linked fluorescent immunoassay (ELFA) in 247 specimens. In addition, toxin B and binary toxin gene were detected by PCR in 57 specimens. CDI was defined by toxigenic C. difficile isolation in unformed stool. RESULTS: In the previous 3 years, 251 unduplicated C. difficile cases have been detected; 168 healthcare facility- associated hospital onset (HCFA-HO), 45 healthcare facility-associated community onset (HCFA-CO), and 38 community-associated (CA). Toxin positive rates by ELFA for toxin A&B were HCFA-HO 50.6% (84/166), HCFA-CO 41.9% (18/43), and CA 42.1% (16/38). Toxin positive rate by PCR for tcdB were HCFA-HO 62.9% (22/35), HCFA-CO 69.2% (9/13), and CA 100% (9/9). No binary toxin (cdtA/cdtB) was detected in 57 cases. CONCLUSION: Community-associated CDI may be underestimated in Goyang province, Korea, especially by commonly used ELFA toxin assay. The spread of community-associated CDI should be recognized as an increasing burden of public health.
Clostridium difficile*
;
Clostridium*
;
Community-Acquired Infections
;
Delivery of Health Care
;
Electronic Health Records
;
Epidemiology
;
Europe
;
Humans
;
Immunoassay
;
Infection Control
;
Korea
;
North America
;
Outpatients
;
Polymerase Chain Reaction
;
Public Health*
6.An Epidemiologic Study on Sudden Deaths of Cattle Occurred in Kyongju.
Hyun Sul LIM ; Hae Kwan CHEONG ; Jung Ran KIM ; Ik Jung KIM ; Gyoung Yim HA
Korean Journal of Epidemiology 2001;23(1):59-68
PURPOSE: This study was conducted to provide the baseline data for the epidemiologic and microbiologic investigation for the etiology of sudden deaths of cattle in Sara-Ri, Seo Myun, Kyongju. METHODS: This survey was performed between April 11 and 22, 1994. Epidemiologic investigation consisted of interview of the residents, as well as pathologic and microbiologic test on tissues and blood samples from cardiac puncture. RESULTS: The dead numbers of cattle were 149 in 35 households during about 20 years. The cows(63.9%) were more than bulls(36.1%) and most of them were raised in playpen(95.7%). The first death occurred in 1974, and then number of deaths increased until 1994. Besides the age of cattle at death was over two years old (88.3%), most of them(69.4%) died within one hour after onset of noticeable symptom by the farmers. The most common symptom of cattle at death was 'sudden death after screaming(71.1%)' and 'seizure (33.3%)'. Colonies from blood of case 3 showed double hemolysis in blood agar plate. The microbiologic test results in the culture of Clostridium perfringens. The pathological features were characterized as most of renal tubules revealed coagulative necrosis. Some gram-positive bacilli are scattered in interstitium. CONCLUSIONS: Above results suggest C. perfringens as a possible pathogen of this ourbreak in livestock. The possibility of human infection, although nonfatal, and lack of vaccination against C. perfringens raises a need for stronger preventive action toward this communicable disease of cattle on this village.
Agar
;
Animals
;
Cattle*
;
Clostridium Infections
;
Clostridium perfringens
;
Communicable Diseases
;
Death, Sudden*
;
Epidemiologic Studies*
;
Epidemiology
;
Family Characteristics
;
Gyeongsangbuk-do*
;
Hemolysis
;
Humans
;
Livestock
;
Necrosis
;
Punctures
;
Vaccination
7.Study on the features of Clostridioides difficile infection among diarrhea patients in Kunming from 2018 to 2020.
Gui Man LI ; Wen Peng GU ; Min HOU ; Sen Quan JIA ; Yuan Yuan WANG ; Lu Lu BAI ; Jian Wen YIN ; Yong Ming ZHOU ; Xiao Qing FU ; Jin Xing LU ; Yuan WU
Chinese Journal of Epidemiology 2023;44(4):624-628
Objective: We analyze the characteristics of Clostridioides difficile (C. difficile) infection among diarrhea patients in Kunming from 2018 to 2020 and provide evidence for follow-up surveillance and prevention. Methods: A total of 388 fecal samples of diarrhea patients from four sentinel hospitals in Yunnan Province from 2018 to 2020 were collected. Real-time quantitative PCR was used to detect the fecal toxin genes of C. difficile. The positive fecal samples isolated the bacteria, and isolates were identified by mass spectrometry. The genomic DNA of the strains was extracted for multi-locus sequence typing (MLST). The fecal toxin, strain isolation, and clinical patient characteristics, including co-infection with other pathogens, were analyzed. Results: Among the 388 fecal samples, 47 samples with positive reference genes of C. difficile were positive, with a total positive rate of 12.11%. There were 4 (8.51%) non-toxigenic and 43 (91.49%) toxigenic ones. A total of 18 strains C. difficile were isolated from 47 positive specimens, and the isolation rate of positive specimens was 38.30%. Among them, 14 strains were positive for tcdA, tcdB, tcdC, tcdR, and tcdE. All 18 strains of C. difficile were negative for binary toxins. The MLST results showed 10 sequence types (ST), including 5 strains of ST37, accounting for 27.78%; 2 strains of ST129, ST3, ST54, and ST2, respectively; and 1 strain of ST35, ST532, ST48, ST27, and ST39, respectively. Fecal toxin gene positive (tcdB+) results were statistically associated with the patient's age group and with or without fever before the visit; positive isolates were only statistically associated with the patient's age group. In addition, some C. difficile patients have co-infection with other diarrhea-related viruses. Conclusions: The infection of C. difficile in diarrhea patients in Kunming is mostly toxigenic strains, and the high diversity of strains was identified using the MLST method. Therefore, the surveillance and prevention of C. difficile should be strengthened.
Humans
;
Bacterial Toxins/genetics*
;
Enterotoxins/genetics*
;
Clostridioides difficile/genetics*
;
Multilocus Sequence Typing
;
Coinfection
;
Bacterial Proteins/genetics*
;
China/epidemiology*
;
Clostridium Infections/epidemiology*
;
Diarrhea/microbiology*
8.Epidemiology and Clinical Characteristics of Clostridium difficile Infection in a Korean Tertiary Hospital.
Jieun KIM ; Hyunjoo PAI ; Mi ran SEO ; Jung Oak KANG
Journal of Korean Medical Science 2011;26(10):1258-1264
In order to investigate the incidence, clinical and microbiologic characteristics of Clostridium difficile infection (CDI) in Korea, a prospective observational study was performed. From September 2008 through January 2010, all patients whose stool was tested for toxin assay A&B and/or C. difficile culture were studied for clinical characteristics. Toxin types of the isolates from stool were tested. The mean incidence of CDI per 100,000 patient-days was 71.6 by month (range, 52.5-114.0), and the ratio of CDI to antibiotic-associated diarrhea was 0.23. Among 200 CDI patients, 37.5% (75/200) was severe CDI based on severity score. Clinical outcome of 189 CDI was as followed; 25.9% (49/189) improved without treatment, 84.3% (118/140) achieved clinical cure and attributed mortality was 0.7% (1/140) with the treatment. Recurrence rate was 21.4% (30/140) and cure without recurrence was 66.4% (93/140). The most common type of toxin was toxin A-positive/toxin B-positive strain (77.5%), toxin A-negative/toxin B-positive strains or binary toxin-producing strains comprised 15.4% or 7.1%, respectively. In conclusion, the incidence of CDI in Korea is a little higher than other reports during the non-epidemic setting. We expect that the change of epidemiology and clinical severity in CDI can be evaluated based on these results.
Aged
;
Bacterial Proteins/analysis
;
Bacterial Toxins/analysis
;
Clostridium Infections/*epidemiology/physiopathology
;
Clostridium difficile/*isolation & purification/*pathogenicity
;
Diarrhea/epidemiology/microbiology
;
Enterocolitis, Pseudomembranous/*epidemiology/microbiology/pathology
;
Enterotoxins/analysis
;
Feces/microbiology
;
Female
;
Hospitals
;
Humans
;
Incidence
;
Male
;
Metronidazole/therapeutic use
;
Middle Aged
;
Prospective Studies
;
Recurrence
;
Republic of Korea/epidemiology
;
Treatment Outcome
;
Vancomycin/therapeutic use
9.Clinical Characteristics and Changing Epidemiology of Clostridium difficile-Associated Disease (CDAD).
Tae Jun BYUN ; Dong Soo HAN ; Sang Bong AHN ; Hyun Seok CHO ; Tae Yeob KIM ; Chang Soo EUN ; Yong Cheol JEON ; Joo Hyun SOHN ; Jung Oak KANG
The Korean Journal of Gastroenterology 2009;54(1):13-19
BACKGROUND/AIMS: The spectrum of Clostridium difficile-associated disease (CDAD) ranges from mild diarrhea to life-threatening colitis. Recent studies reported an increase in incidence and severity of CDAD and the presence of severe community-acquired CDAD (CA-CDAD). The aims of this study were to investigate the incidence of CA-CDAD and non-antibiotics-associated CDAD, and to compare the clinical characteristics between hospital-acquired (HA) and CA-CDAD. METHODS: The medical records of 86 patients who were diagnosed as CDAD in Hanyang University Guri Hospital between January 2005 and October 2007 were retrospectively reviewed. RESULTS: Of the 86 patients (mean age 64 years), 53 patients were women. The most frequently prescribed antibiotics were cephalosporins (67.4%), followed by aminoglycosides (38.4%) and quinolones (14%). Of the 86 patients, the average duration of treatment and recovery time of symptoms were 11.5 days and 4.6 days, respectively. Seven percent of patients experienced relapse treatment. The overall incidence rate of CA-CDAD and non-antibiotics-associated CDAD were 10.5% and 22.1%, respectively. CA-CDAD group had lower rate of antimicrobial exposure whilst showing higher rate of complications compared to HA-CDAD group. Three patients in the CA-CDAD progressed towards a severe complicated clinical course, including septic shock. CONCLUSIONS: The incidence rate of CA-CDAD and non-antibiotics-associated CDAD were 10.5% and 22.1%, respectively. CA-CDAD tends to have a higher complication rate compared to HA-CDAD. Community clinicians needs to maintain a high level of suspicion for CDAD, whilst coping with the ever evolving epidemiologic change.
Adult
;
Aged
;
Aged, 80 and over
;
Aminoglycosides/therapeutic use
;
Anti-Bacterial Agents/therapeutic use
;
Bacterial Toxins/analysis
;
Cephalosporins/therapeutic use
;
*Clostridium difficile
;
Community-Acquired Infections/epidemiology
;
Cross Infection/epidemiology
;
Enterocolitis, Pseudomembranous/*diagnosis/drug therapy/epidemiology
;
Enterotoxins/analysis
;
Female
;
Humans
;
Male
;
Metronidazole/therapeutic use
;
Middle Aged
;
Quinolones/therapeutic use
;
Retrospective Studies